Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dysregulation of cytokine mediated chemotherapy induced cognitive impairment
Xiaojia Ren, Daret K. St. Clair, D. Allan Butterfield
Pharmacological Research (2017) Vol. 117, pp. 267-273
Closed Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue
Theoharis C. Theoharides, Christos Cholevas, Konstantinos S. Polyzoidis, et al.
BioFactors (2021) Vol. 47, Iss. 2, pp. 232-241
Open Access | Times Cited: 189
Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents
Neife Aparecida Guinaim dos Santos, Rafaela Scalco Ferreira, Antônio C. Santos
Food and Chemical Toxicology (2019) Vol. 136, pp. 111079-111079
Open Access | Times Cited: 158
Mechanisms of Chemotherapy-Induced Neurotoxicity
Halina Waś, Agata Borkowska, Ana Bagüés, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 134
Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management
Ben Fleming, Paul Edison, Laura Kenny
BMJ (2023), pp. e071726-e071726
Closed Access | Times Cited: 43
Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”)
Jeriel T. R. Keeney, Xiaojia Ren, Govind Warrier, et al.
Oncotarget (2018) Vol. 9, Iss. 54, pp. 30324-30339
Open Access | Times Cited: 136
Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases
Lien D. Nguyen, Barbara E. Ehrlich
EMBO Molecular Medicine (2020) Vol. 12, Iss. 6
Open Access | Times Cited: 128
Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study
Kimberly D. van der Willik, Vincent Koppelmans, Michael Hauptmann, et al.
Breast Cancer Research (2018) Vol. 20, Iss. 1
Open Access | Times Cited: 123
Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”), a condition that significantly impairs the quality of life of many cancer survivors
Xiaojia Ren, Diana Boriero, Luksana Chaiswing, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1865, Iss. 6, pp. 1088-1097
Open Access | Times Cited: 100
Chemotherapy-Induced Cognitive Impairment Is Associated with Increased Inflammation and Oxidative Damage in the Hippocampus
Ciara Bagnall-Moreau, Sovira Chaudhry, Kaliris Y. Salas-Ramirez, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 10, pp. 7159-7172
Open Access | Times Cited: 93
The immune modifying effects of chemotherapy and advances in chemo-immunotherapy
Daniel R. Principe, Suneel D. Kamath, Murray Korc, et al.
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108111-108111
Open Access | Times Cited: 45
The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment (“chemobrain”) involving TNF-α
Xiaojia Ren, Jeriel T. R. Keeney, Sumitra Miriyala, et al.
Free Radical Biology and Medicine (2018) Vol. 134, pp. 1-8
Open Access | Times Cited: 73
“Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease
Chinthalapally V. Rao, Adam S. Asch, Daniel J.J. Carr, et al.
Aging Cell (2020) Vol. 19, Iss. 3
Open Access | Times Cited: 55
Pathogenesis, Assessments, and Management of Chemotherapy-Related Cognitive Impairment (CRCI): An Updated Literature Review
Longqin Lv, Shanping Mao, Huimin Dong, et al.
Journal of Oncology (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 54
Nanotechnology Approaches for Prevention and Treatment of Chemotherapy‐Induced Neurotoxicity, Neuropathy, and Cardiomyopathy in Breast and Ovarian Cancer Survivors
Sarah Nevins, Callan D. McLoughlin, Alfredo Oliveros, et al.
Small (2023)
Open Access | Times Cited: 17
Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication
Meritxell Bellet, Faten Ahmad, Rafael Villanueva-Vázquez, et al.
Therapeutic Advances in Medical Oncology (2019) Vol. 11
Open Access | Times Cited: 50
An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants
Ankit Das, Niraja Ranadive, Manas Kinra, et al.
Current Neuropharmacology (2020) Vol. 18, Iss. 9, pp. 838-851
Open Access | Times Cited: 47
Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE
Harvey R. Fernandez, Ashima Varma, Sarah A. Flowers, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3842-3842
Open Access | Times Cited: 43
Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment
Ning Yi Yap, Yi Long Toh, Chia Jie Tan, et al.
Cytokine (2021) Vol. 144, pp. 155556-155556
Open Access | Times Cited: 40
Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System
Taurean Brown, DeLawrence Sykes, Antiño R. Allen
Biomedicines (2021) Vol. 9, Iss. 2, pp. 189-189
Open Access | Times Cited: 33
Nose to brain delivery of naringin-loaded chitosan nanoparticles for potential use in oxaliplatin-induced chemobrain in rats: impact on oxidative stress, cGAS/STING and HMGB1/RAGE/TLR2/MYD88 inflammatory axes
Diana M. F. Hanna, John Youshia, Sarah Fahmy, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 12, pp. 1859-1873
Open Access | Times Cited: 12
Alpha-Lipoic Acid Ameliorates Doxorubicin-Induced Cognitive Impairments by Modulating Neuroinflammation and Oxidative Stress via NRF-2/HO-1 Signaling Pathway in the Rat Hippocampus
Roshan Lal, Ravinder Naik Dharavath, Kanwaljit Chopra
Neurochemical Research (2023) Vol. 48, Iss. 8, pp. 2476-2489
Closed Access | Times Cited: 11
Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study
Mylène Duivon, Justine Lequesne, Antonio Di Meglio, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 4
Chemotherapy and Inflammatory Cytokine Signalling in Cancer Cells and the Tumour Microenvironment
Derek Edwardson, Amadeo M. Parissenti, A. Thomas Kovala
Advances in experimental medicine and biology (2019), pp. 173-215
Closed Access | Times Cited: 33
Chemobrain as a Product of Growing Success in Chemotherapy - Focus On Glia As Both A Victim And A Cure
Piotr Walczak, Mirosław Janowski
Neuropsychiatry (2019) Vol. 09, Iss. 01
Open Access | Times Cited: 30
Cancer-related cognitive impairment is associated with perturbations in inflammatory pathways
Kate Oppegaard, Carolyn Harris, Joosun Shin, et al.
Cytokine (2021) Vol. 148, pp. 155653-155653
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top